Bioactive metabolites from an endophytic Cryptosporiopsis sp. inhabiting Clidemia hirta

Phytochemistry. 2013 Nov:95:291-7. doi: 10.1016/j.phytochem.2013.06.021. Epub 2013 Jul 17.

Abstract

An endophytic Cryptosporiopsis sp. was isolated from Clidemia hirta and analyzed for its secondary metabolites that lead to the isolation of three bioactive molecules. The compounds were purified from the culture broth of the fungus and their structures were determined by spectroscopic methods as (R)-5-hydroxy-2-methylchroman-4-one (1), 1-(2,6-dihydroxyphenyl)pentan-1-one (2) and (Z)-1-(2-(2-butyryl-3-hydroxyphenoxy)-6-hydroxyphenyl)-3-hydroxybut-2-en-1-one (3). Compound 1 exhibited significant cytotoxic activity against the human leukemia cell line, HL-60 with an IC50 of 4 μg/ml. This compound induced G2 arrest of the HL-60 cell cycle significantly. In addition, out of these compounds, 2 and 3 were active against several bacterial pathogens. Compound 2 was active against Bacillus cereus, Escherichia coli and Staphylococcus aureus with IC50 values varying from 18 to 30 μg/ml, and compound 3 displayed activity against Pseudomonas fluorescens with an IC50 value of 6 μg/ml. Compounds 2 and 3 are novel whereas compound 1 was reported earlier but the stereochemistry of its C-2 methyl is established for the first time.

Keywords: Antimicrobial activity; Clidemia hirta; Cryptosporiopsis; Cytotoxicity; Endophytes; Natural products.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / isolation & purification
  • Anti-Bacterial Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Ascomycota / chemistry*
  • Bacillus / drug effects
  • Bacteria / drug effects*
  • Biological Products / chemistry
  • Biological Products / pharmacology
  • Biological Products / therapeutic use
  • Butyrophenones / chemistry
  • Butyrophenones / isolation & purification
  • Butyrophenones / pharmacology*
  • Cell Cycle Checkpoints / drug effects
  • Chromones / chemistry
  • Chromones / isolation & purification
  • Chromones / pharmacology
  • Chromones / therapeutic use*
  • Endophytes / chemistry
  • Escherichia coli / drug effects
  • HL-60 Cells
  • Humans
  • Inhibitory Concentration 50
  • Leukemia / drug therapy*
  • Melastomataceae / microbiology*
  • Molecular Structure
  • Pentanones / chemistry
  • Pentanones / isolation & purification
  • Pentanones / pharmacology*
  • Pseudomonas fluorescens / drug effects
  • Staphylococcus aureus / drug effects

Substances

  • 1-(2,6-dihydroxyphenyl)pentan-1-one
  • 1-(2-(2-butyryl-3-hydroxyphenoxy)-6-hydroxyphenyl)-3-hydroxybut-2-en-1-one
  • 5-hydroxy-2-methylchroman-4-one
  • Anti-Bacterial Agents
  • Antineoplastic Agents
  • Biological Products
  • Butyrophenones
  • Chromones
  • Pentanones